The lysosome-mediated degradation pathway known as macroautophagy is the most versatile means through which cells can eliminate and recycle unwanted materials. Through both selective and non-selective means, macroautophagy can degrade a wide range of cargoes from bulk cytosol to organelles and aggregated proteins. Although studies of disorders such as Parkinson's disease and Amyotrophic Lateral Sclerosis suggest that autophagic and lysosomal dysfunction directly contributes to disease, this had not been the case for the polyglutamine disorder Huntington's disease (HD), for which there was little indication of a disruption in the autophagic-lysosomal system. This supported the possibility of targeting autophagy as a much needed therapeutic approach to combat this disease. Possibly challenging this view, however, are a recent set of studies suggesting that the protein affected in Huntington's disease, huntingtin, might mechanistically contribute to macroautophagy. In this review, we will explore how autophagy might impact or be impacted by HD pathogenesis, and whether a therapeutic approach centering on autophagy may be possible for this yet incurable disease.
Introduction
Huntington's disease is an autosomal-dominantly inherited neurodegenerative disease characterized by cognitive dysfunction, psychiatric disturbances and severe motor dysfunction (Sturrock and Leavitt, 2010) . The primary site of neurodegeneration is the medium spiny neurons of the caudate putamen, which worsens in a dorsomedial to ventrolateral direction, whereas the interneurons of the region are largely spared (Vonsattel et al., 2011) ). As the severity of pathology worsens, the affected regions broaden to include regions of the cortex, cerebellum, thalamus and white matter (Vonsattel et al., 2011) . The age of onset is typically midlife, and the duration of the disease can extend through decades (Sturrock and Leavitt, 2010; Vonsattel et al., 2011) .
In a landmark study of reverse genetics in 1998, the genetic cause of HD was identified as a trinucleotide repeat expansion mutation of cysteine, adenine, and guanine (CAG) in the coding region of the ubiquitously expressed gene now known as the HD gene (HDCRG, 1993) . At the protein level, the mutation leads to the production of abnormally long tracts of polyglutamine (polyQ) repeats near the N-terminus of the HD gene product, huntingtin (Htt) (Gusella et al., 1993; Hoogeveen et al., 1993; Li et al., 1993) . One of the most marked features of the mutant protein is its propensity to accumulate and aggregate (Perutz et al., 1994; Scherzinger et al., 1997; Bauerlein et al., 2017) and to form the intranuclear and intracytoplasmic neuronal inclusions which are now considered a pathological hallmark of the disease (Roizin et al., 1979; Davies et al., 1997; Difiglia et al., 1997; Gutekunst et al., 1999) . Given that the rediscovery of protein aggregation in this disease was due to the creation of the first HD mouse model, the R6/2 model (Mangiarini et al., 1996; Davies et al., 1997; Difiglia et al., 1997) , much of what we understand about HD is based on experimental model systems, and validation in patient material is limited (Vonsattel, 2008; Cepeda et al., 2010) . A recent study using neurons generated from human HD fibroblasts however suggests that mechanistic validation using endogenously expressed mutant Htt might soon be forth coming (Victor et al., 2018) .
The presence of the polyQ expansion at the NH3-terminus of Htt, as well as the fact that Htt can be proteolyzed to shorter fragments (Goldberg et al., 1996; Kim et al., 2001; Mende-Mueller et al., 2001; Lunkes et al., 2002; Graham et al., 2006; Landles et al., 2010; Bhat et al., 2014) raised question as to what form of the protein was preferentially accumulating: A short NH3-terminal fragment of the Htt protein (of which there are several possible lengths); the complete 348 kDa protein with the polyQ expansion; or a combination of both. Although it is clear from single cell-based systems to in vivo models such as flies and mice that the kinetics of aggregation is significantly affected by the length of the Htt protein itself, it is difficult to know how relevant these differences might be in a disease that onsets mid-life and lasts for decades. To further complicate matters, more recent studies using Htt fragment-and full length-models suggest that the trinucleotide repeat mutation might also be problematic at the level of RNA, leading to the production and accumulation of proteins containing dipeptide repeats (Banez-Coronel et al., 2015) , to alternative splicing (Neueder and Bates, 2018) , as well as to the creation of RNA foci (Rudnicki et al., 2008; de Mezer et al., 2011; Krzyzosiak et al., 2012;  https://doi.org/10.1016/j.nbd.2018.08.010 Received 30 April 2018; Received in revised form 10 August 2018; Accepted 23 August 2018
